Prytime Medical Devices, Inc., an innovative medical device company that designs, develops and commercializes minimally invasive solutions for hemorrhage control.
The company’s flagship product is the pREBOA-PRO™ Catheter, a 7 Fr compatible balloon catheter designed specifically for rapid, True Partial™ aortic occlusion in the emergency and critical care environment. The pREBOA-PRO Catheter is the first and only catheter cleared by the FDA for partial REBOA and is designed to provide surgeons proximal control with continuous distal blood flow.
The underlying intellectual property for the ER-REBOA™ Catheter was invented by experienced military vascular and trauma surgeons, COL. Todd Rasmussen and Dr. Jonathan Eliason, based on lessons learned on the battlefront during combat.
The first guidewire free prototype was developed and tested on animals in 2011. Shortly thereafter, the company was founded. In October 2015 the ER-REBOA™ Catheter received 510(K) clearance, and we began commercializing the device in the U.S. market in 2016, followed by the European market. After several years of engineering design and use advancements, the pREBOA-PRO Catheter (PRO) was created. The PRO received 510(K) clearance in June 2020, with an additional 510(K) Clearance in September 2025 for two hours of partial occlusion in zone 1, and use of the device is continuing to increase worldwide.
At Prytime, we are proud to be a part of bringing military medical innovation to the civilian marketplace. We believe that no one should bleed to death; and the sooner you stop bleeding, the better.
Comments are closed.